CD79A and nasopharyngeal carcinoma: The combination of P85-Ab with VCA-IgA and Rta-IgG showed excellent performance in terms of sensitivity and specificity, which highlighted its potential as a large-scale NPC screening method in regions with a relatively low incidence of NPC.